OncoCyte Corp (OCX) — Strategic Asset Allocation Index
OncoCyte Corp (OCX) has a Strategic Asset Allocation Index of 18.1% as of June 2023. Strategic assets (PP&E of $7.89 Million plus long-term investments of $-) total $7.89 Million, measured against net assets of $43.60 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of OncoCyte Corp to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
OncoCyte Corp Strategic Asset Allocation Index (2013–2021)
This chart shows how OncoCyte Corp's Strategic Asset Allocation Index has evolved across 8 annual periods from 2013 to 2021. As of June 2023, the index stands at 18.1%, representing strategic assets of $7.89 Million against net assets of $43.60 Million USD. For live market cap and overall valuation, see market cap of OncoCyte Corp.
Annual Strategic Asset Allocation Index for OncoCyte Corp (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for OncoCyte Corp from 2013 to 2021, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See OCX net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 13.1% | $8.53 Million | $8.53 Million | $0.00 | $65.22 Million | ▼ -46.5 pp |
| 2020 | 59.6% | $19.94 Million | $6.52 Million | $13.42 Million | $33.48 Million | ▲ +11.9 pp |
| 2019 | 47.6% | $14.69 Million | $3.73 Million | $10.96 Million | $30.84 Million | ▲ +29.7 pp |
| 2018 | 17.9% | $614.00K | $614.00K | $- | $3.42 Million | ▼ -0.7 pp |
| 2017 | 18.7% | $822.00K | $822.00K | $- | $4.40 Million | ▲ +11.7 pp |
| 2016 | 7.0% | $688.00K | $688.00K | $- | $9.86 Million | ▲ +1.4 pp |
| 2015 | 5.5% | $576.00K | $576.00K | $- | $10.42 Million | ▲ +1.4 pp |
| 2013 | 4.1% | $148.00K | $148.00K | $- | $3.62 Million | — |